Edwards Competitors

E1WL34 Stock

103.20 2.90 2.89%

Edwards Lifesciences competes with United States, Mangels Industrial, CVS Health, Multilaser Industrial, and American Airlines; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing Edwards Lifesciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Edwards Lifesciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Edwards Lifesciences Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Edwards Lifesciences competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
101.30	103.20	105.10

Details

Intrinsic

Valuation

Low	Real	High
97.46	99.36	113.52

Details

Naive

Forecast

Low	Next	High
106.24	108.15	110.05

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
92.99	98.23	103.46

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Edwards Lifesciences. Your research has to be compared to or analyzed against Edwards Lifesciences' peers to derive any actionable benefits. When done correctly, Edwards Lifesciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Edwards Lifesciences.

Edwards Lifesciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Edwards Lifesciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Edwards and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Edwards Lifesciences does not affect the price movement of the other competitor.

	USSX34	MGEL4	CVSH34	MLAS3	AALL34	MTSA4	RSUL4
USSX34		-0.71	-0.19	-0.4	0.64	-0.49	-0.54	USSX34
MGEL4	-0.71		-0.03	0.64	-0.96	0.8	0.7	MGEL4
CVSH34	-0.19	-0.03		-0.26	0.09	-0.23	-0.14	CVSH34
MLAS3	-0.4	0.64	-0.26		-0.73	0.88	0.87	MLAS3
AALL34	0.64	-0.96	0.09	-0.73		-0.87	-0.76	AALL34
MTSA4	-0.49	0.8	-0.23	0.88	-0.87		0.85	MTSA4
RSUL4	-0.54	0.7	-0.14	0.87	-0.76	0.85		RSUL4
	USSX34	MGEL4	CVSH34	MLAS3	AALL34	MTSA4	RSUL4

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

MTSA4	+ 0.88	MLAS3
RSUL4	+ 0.87	MLAS3
RSUL4	+ 0.85	MTSA4
MTSA4	+ 0.8	MGEL4
RSUL4	+ 0.7	MGEL4
AALL34	+ 0.64	USSX34

High negative correlations

AALL34	- 0.96	MGEL4
MTSA4	- 0.87	AALL34
RSUL4	- 0.76	AALL34
AALL34	- 0.73	MLAS3
MGEL4	- 0.71	USSX34
RSUL4	- 0.54	USSX34

Risk-Adjusted Indicators

There is a big difference between Edwards Stock performing well and Edwards Lifesciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Edwards Lifesciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
USSX34	2.23	0.19	0.01	(0.31)	4.26	(2.23)	6.57	(3.70)	27.79
MGEL4	1.78	(0.73)	0.00	(1.84)	0.00	0.00	1.40	(4.35)	21.44
CVSH34	1.77	0.05	(0.01)	0.35	2.66	(1.80)	3.44	(3.90)	23.09
MLAS3	2.44	(0.47)	0.00	(0.89)	0.00	0.00	6.45	(5.10)	13.47
AALL34	1.84	0.63	0.27	(1.43)	1.40	(2.22)	4.96	(2.88)	12.10
MTSA4	1.70	(0.34)	0.00	(7.42)	0.00	0.00	3.01	(3.40)	9.25
RSUL4	0.98	(0.18)	0.00	(0.48)	0.00	0.00	1.96	(2.22)	6.19

Unable to evaluate fundamental data of [USSX34.SA, MGEL4.SA, CVSH34.SA, MLAS3.SA, AALL34.SA, MTSA4.SA, RSUL4.SA] at this time. Please try again later

All Fundamental Data

Edwards Lifesciences Competitive Analysis

The better you understand Edwards Lifesciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Edwards Lifesciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Edwards Lifesciences' competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	E1WL34	USSX34	MGEL4	CVSH34	MLAS3	AALL34	MTSA4	RSUL4
	2.89 103.20 Edwards	3.70 224.18 United	0.42 7.10 Mangels	1.86 32.94 CVS	3.55 1.36 Multilaser	0.53 82.23 American	1.33 34.18 METISA	1.03 59.00 Metalrgica
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Slightly risky	Not too volatile	Very risky	Very steady	Very steady	Very steady
Market Performance (90 Days Performance)	Modest	Insignificant	Very Weak	Weak	Very Weak	Solid	Very Weak	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Low	Low	Low	Low	Low	Low	Low
Current Valuation (Equity Enterprise Value)	Fairly Valued	Over Valued	Fairly Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Cautious Hold	Strong Sell	Cautious Hold
Current Ratio	N/A	1.27 X	2.25 X	2.34 X	N/A	1.05 X	4.13 X	0.46 X
Net Asset	8.5 B	17.82 B	590.34 M	228.28 B	6.68 B	64.72 B	467.87 M	284.02 M
Profit Margin	0.28 %	0.12 %	0.08 %	0.01 %	0.1 %	0 %	0.11 %	0.16 %
EBITDA	1.86 B	5.45 B	245.15 M	12.16 B	886.06 M	2.15 B	85.98 M	116.72 M
Operating Margin	0.33 %	0.16 %	0.21 %	0.05 %	0.11 %	0.04 %	0.15 %	0.25 %
Current Valuation	243.98 B	34.89 B	739.73 M	971.11 B	3.14 B	223.09 B	439.18 M	421.78 M
Price To Book	1.89 X	0.58 X	N/A	1.86 X	0.62 X	N/A	0.91 X	3.54 X
Beta	1.0	2.16	0.86	0.65	N/A	1.54	0.89	-0.25
Number Of Employees	10	22.74 K	16	219 K	5 K	129.7 K	1.14 K	951
Shares Outstanding	618.26 M	226.6 M	3.72 M	12.84 B	812.65 M	650.64 M	4.58 M	2.41 M
Cash Flow From Operations	1.73 B	4.09 B	59.61 M	16.18 B	(855.74 M)	2.17 B	(38.96 M)	34.85 M
Annual Yield	N/A	0.01 %	N/A	0.02 %	0.05 %	0.02 %	0.05 %	0.03 %
Total Debt	595.7 M	3.86 B	694.36 M	50.48 B	392.5 M	32.39 B	39.24 K	10.03 M
Return On Equity	0.26	0.26	N/A	0.0568	0.11	N/A	0.24	0.66
Z Score	N/A	5.8	1.0	8.2	3.0	0.6	N/A	8.8
Return On Asset	0.13	0.11	0.21	0.0418	0.0416	0.0172	0.14	0.2
Book Value Per Share	2.37 X	44.74 X	(32.70) X	27.31 X	5.24 X	(8.91) X	42.37 X	20.90 X
Total Asset	8.5 B	17.82 B	590.34 M	228.28 B	6.68 B	64.72 B	467.87 M	284.02 M
Debt To Equity	N/A	0.97 %	N/A	182.80 %	N/A	N/A	7.80 %	0.73 %
Last Dividend Paid	N/A	0.2	N/A	2.2	0.12	N/A	1.38	N/A
Target Price	N/A	N/A	N/A	N/A	7.0	N/A	N/A	N/A
Shares Owned By Institutions	N/A	0.01 %	11.32 %	N/A	20.47 %	0.59 %	17.00 %	16.61 %
Market Capitalization	250.86 B	33.78 B	44.41 M	609.34 B	2.12 B	56.42 B	512.88 M	136.16 M
Price To Earnings To Growth	0.77 X	N/A	N/A	1.35 X	N/A	0.68 X	N/A	N/A
Price To Earning	N/A	6.17 X	0.42 X	46.57 X	N/A	N/A	11.53 X	4.73 X
Price To Sales	44.79 X	1.33 X	0.04 X	2.16 X	0.59 X	0.99 X	0.61 X	0.44 X
Net Income	1.5 B	4.17 B	149.33 M	4.15 B	774.72 M	127 M	53.19 M	88.79 M
Earnings Per Share	12.51 X	48.48 X	14.97 X	1.59 X	0.55 X	0.96 X	8.90 X	10.83 X
Shares Owned By Insiders	N/A	N/A	59.21 %	N/A	78.23 %	N/A	32.80 %	62.65 %
Revenue	5.23 B	20.27 B	862.97 M	322.47 B	4.85 B	48.97 B	583.84 M	322.2 M
Cash And Equivalents	N/A	1.33 B	33.48 M	43.91 B	1.28 B	17.95 B	64.31 M	782 K
Cash Per Share	N/A	4.92 X	2.54 X	43.13 X	N/A	27.72 X	7.69 X	13.00 X
Gross Profit	4.3 B	4.35 B	130.75 M	53.46 B	1.36 B	11.34 B	162.84 M	120.42 M
Day Typical Price	102.89	223.65	7.12	33.07	1.37	82.95	34.2	58.61
Accumulation Distribution	0.009	0.0117	0.007	0.0117	0.0288	0.0256	61.03	0.0198
Market Facilitation Index	0.93	2.64	0.05	0.39	0.04	2.16	4.0E-4	1.17
Daily Balance Of Power	3.11828	3.030303	(0.60)	1.538462	(1.25)	(0.20)	0.4891	0.5128
Period Momentum Indicator	2.9	8.0	(0.03)	0.6	(0.05)	(0.44)	0.45	0.6
Rate Of Daily Change	1.03	1.04	1.0	1.02	0.96	0.99	1.01	1.01
Day Median Price	102.74	223.38	7.13	33.14	1.37	83.31	34.21	58.42
Price Action Indicator	1.92	4.8	(0.04)	0.1	(0.04)	(1.30)	0.2	0.89
Coefficient Of Variation	1328.56	2831.29	(435.62)	3694.81	(766.26)	401.45	(656.95)	(966.99)
Mean Deviation	1.41	2.23	1.78	1.77	2.44	1.84	1.7	0.9764
Jensen Alpha	0.195	0.1918	(0.73)	0.0479	(0.47)	0.6276	(0.34)	(0.18)
Total Risk Alpha	(0.12)	(0.43)	(1.07)	(0.30)	(0.84)	0.2743	(0.61)	(0.32)
Sortino Ratio	0.0208	0.0068	N/A	(0.01)	N/A	0.2685	N/A	N/A
Downside Variance	3.4	44.82	N/A	9.18	N/A	3.29	N/A	N/A
Standard Deviation	1.96	4.39	2.96	2.84	3.19	2.4	2.11	1.32
Kurtosis	2.55	15.73	6.81	8.77	0.3862	0.6423	0.0881	0.5966
Potential Upside	3.28	6.57	1.4	3.44	6.45	4.96	3.01	1.96
Treynor Ratio	(0.24)	(0.31)	(1.84)	0.3487	(0.89)	(1.43)	(7.42)	(0.48)
Maximum Drawdown	10.94	27.79	21.44	23.09	13.47	12.1	9.25	6.19
Variance	3.86	19.29	8.74	8.08	10.14	5.74	4.46	1.75
Market Risk Adjusted Performance	(0.23)	(0.30)	(1.83)	0.3587	(0.88)	(1.42)	(7.41)	(0.47)
Risk Adjusted Performance	0.0635	0.0352	(0.17)	0.028	(0.09)	0.1968	(0.11)	(0.07)
Skewness	0.6611	(2.50)	0.7801	0.9751	0.735	0.6234	0.5061	(0.55)
Semi Deviation	1.56	4.26	N/A	2.66	N/A	1.4	N/A	N/A
Information Ratio	0.0195	0.0104	(0.27)	(0.01)	(0.16)	0.2034	(0.20)	(0.19)
Value At Risk	(2.96)	(3.70)	(4.35)	(3.90)	(5.10)	(2.88)	(3.40)	(2.22)
Expected Short fall	(1.65)	(2.23)	N/A	(1.80)	N/A	(2.22)	N/A	N/A
Downside Deviation	1.84	6.69	N/A	3.03	N/A	1.81	N/A	N/A
Semi Variance	2.42	18.18	N/A	7.09	N/A	1.97	N/A	N/A

Edwards Lifesciences Competition Performance Charts

Five steps to successful analysis of Edwards Lifesciences Competition

Edwards Lifesciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Edwards Lifesciences in relation to its competition. Edwards Lifesciences' competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Edwards Lifesciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Edwards Lifesciences' competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Edwards Lifesciences, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Edwards Lifesciences position

In addition to having Edwards Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Theme ETFs Thematic Idea Now

Theme ETFs

ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Theme ETFs theme has 483 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Theme ETFs Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Edwards Stock

Edwards Lifesciences financial ratios help investors to determine whether Edwards Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Edwards with respect to the benefits of owning Edwards Lifesciences security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Edwards Competitors

Specify up to 10 symbols:

Edwards Lifesciences Competition Correlation Matrix

Risk-Adjusted Indicators

Edwards Lifesciences Competitive Analysis

Edwards Lifesciences Competition Performance Charts

Five steps to successful analysis of Edwards Lifesciences Competition

Complement your Edwards Lifesciences position

Did You Try This Idea?

Run Theme ETFs Thematic Idea Now

Theme ETFs

Other Information on Investing in Edwards Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY